Back to Journals » Vascular Health and Risk Management » Volume 4 » Issue 6

Long-acting nifedipine in the management of the hypertensive patient

Authors Snider, Nuzum D, Veverka A

Published 5 December 2008 Volume 2008:4(6) Pages 1249—1257

DOI https://doi.org/10.2147/VHRM.S3661

Review by Single anonymous peer review

Peer reviewer comments 2



Morgan E Snider1, Donald S Nuzum2, Angie Veverka2

1Virginia Commonwealth University Health Systems Richmond, VA USA; 2Wingate University School of Pharmacy Wingate, NC USA

Abstract: Hypertension is a global condition affecting billions worldwide. It is a significant contributor to cardiovascular events, cardiac death and kidney disease. A number of medication classes exist to aid healthcare providers and their patients in controlling hypertension. Nifedipine, a dihydropyridine calcium channel blocker, was once one of the most widely used medications for hypertension, but safety and tolerability concerns along with the introduction of new classes of antihypertensive medications and an increasing pool of data showing mortality benefit of other classes caused nifedipine to fall out of favor. More recently, long-acting formulations were developed and made available to clinicians. These newer formulations were designed to address many of the concerns raised by earlier formulations of nifedipine. Numerous clinical trials have been conducted comparing long-acting nifedipine to many of the more commonly prescribed antihypertensive medications. This review will address the pharmacology, pharmacokinetics and the available clinical trial data on long-acting nifedipine and summarize its role in the management of hypertension.

Keywords: nifedipine, calcium channel blockers, hypertension

Creative Commons License © 2008 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.